214 related articles for article (PubMed ID: 28730476)
1. Proteomic Profiling of Protein Kinase Inhibitor Targets by Mass Spectrometry.
Golkowski M; Maly DJ; Ong SE
Methods Mol Biol; 2017; 1636():105-117. PubMed ID: 28730476
[TBL] [Abstract][Full Text] [Related]
2. [Advances in high-throughput proteomic analysis].
Wu Q; Sui X; Tian R
Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
[TBL] [Abstract][Full Text] [Related]
3. Multiplex imaging and cellular target identification of kinase inhibitors via an affinity-based proteome profiling approach.
Su Y; Pan S; Li Z; Li L; Wu X; Hao P; Sze SK; Yao SQ
Sci Rep; 2015 Jan; 5():7724. PubMed ID: 25579846
[TBL] [Abstract][Full Text] [Related]
4. Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.
Golkowski M; Vidadala RS; Lombard CK; Suh HW; Maly DJ; Ong SE
J Proteome Res; 2017 Mar; 16(3):1216-1227. PubMed ID: 28102076
[TBL] [Abstract][Full Text] [Related]
5. An off-line high pH reversed-phase fractionation and nano-liquid chromatography-mass spectrometry method for global proteomic profiling of cell lines.
Wang H; Sun S; Zhang Y; Chen S; Liu P; Liu B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():90-5. PubMed ID: 25463202
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Proteomic Analysis of the Human Nucleolus.
Bensaddek D; Nicolas A; Lamond AI
Methods Mol Biol; 2016; 1455():249-62. PubMed ID: 27576725
[TBL] [Abstract][Full Text] [Related]
7. Drug Target Identification Using an iTRAQ-Based Quantitative Chemical Proteomics Approach-Based on a Target Profiling Study of Andrographolide.
Wang J; Wong YK; Zhang J; Lee YM; Hua ZC; Shen HM; Lin Q
Methods Enzymol; 2017; 586():291-309. PubMed ID: 28137568
[TBL] [Abstract][Full Text] [Related]
8. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
Kreimer S; Ivanov AR
Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Interactome Mapping by Photo-Affinity Labeling (SIM-PAL) to Identify Binding Sites of Small Molecules on a Proteome-Wide Scale.
Flaxman HA; Miyamoto DK; Woo CM
Curr Protoc Chem Biol; 2019 Dec; 11(4):e75. PubMed ID: 31763793
[TBL] [Abstract][Full Text] [Related]
10. Profiling Cell Lines Nuclear Sub-proteome.
Poersch A; Maria AG; Palma CS; Grassi ML; Albuquerque D; Thomé CH; Faça VM
Methods Mol Biol; 2017; 1550():35-46. PubMed ID: 28188521
[TBL] [Abstract][Full Text] [Related]
11. The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells.
Vasilescu J; Zweitzig DR; Denis NJ; Smith JC; Ethier M; Haines DS; Figeys D
J Proteome Res; 2007 Jan; 6(1):298-305. PubMed ID: 17203973
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry Profiling of Pituitary Glands.
Krishnamurthy D; Rahmoune H; Guest PC
Methods Mol Biol; 2018; 1735():439-447. PubMed ID: 29380334
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
Gritsenko MA; Xu Z; Liu T; Smith RD
Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
[TBL] [Abstract][Full Text] [Related]
14. Digestion, Purification, and Enrichment of Protein Samples for Mass Spectrometry.
Hedrick VE; LaLand MN; Nakayasu ES; Paul LN
Curr Protoc Chem Biol; 2015 Sep; 7(3):201-222. PubMed ID: 26331527
[TBL] [Abstract][Full Text] [Related]
15. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
Zhang L; Holmes IP; Hochgräfe F; Walker SR; Ali NA; Humphrey ES; Wu J; de Silva M; Kersten WJ; Connor T; Falk H; Allan L; Street IP; Bentley JD; Pilling PA; Monahan BJ; Peat TS; Daly RJ
J Proteome Res; 2013 Jul; 12(7):3104-16. PubMed ID: 23692254
[TBL] [Abstract][Full Text] [Related]
17. Shotgun Proteomics and Mass Spectrometry as a Tool for Protein Identification and Profiling of Bio-Carrier-Based Therapeutics on Human Cancer Cells.
Abidin SAZ; Othman I; Naidu R
Methods Mol Biol; 2021; 2211():233-240. PubMed ID: 33336281
[TBL] [Abstract][Full Text] [Related]
18. Optimized chemical proteomics assay for kinase inhibitor profiling.
Médard G; Pachl F; Ruprecht B; Klaeger S; Heinzlmeir S; Helm D; Qiao H; Ku X; Wilhelm M; Kuehne T; Wu Z; Dittmann A; Hopf C; Kramer K; Kuster B
J Proteome Res; 2015 Mar; 14(3):1574-86. PubMed ID: 25660469
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
Sun CS; Markey MK
J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
[TBL] [Abstract][Full Text] [Related]
20. Flow field-flow fractionation: a pre-analytical method for proteomics.
Reschiglian P; Moon MH
J Proteomics; 2008 Aug; 71(3):265-76. PubMed ID: 18602503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
